Maud Maillard, PhD, PharmD is an expert in Pharmacy at Oncopole Claudius Regaud (France). Maud Maillard has authored 11 publications, the most recent in 2026. SLR score: 64 (community average: 125). How the SLR is computed.

LeadR Profile

Maud Maillard, PhD, PharmD Oncopole Claudius Regaud France
64 ScienceLeadR Reputation 64
Network Map

Pharmacy

Subspecialties: Genetics - Oncology - Hematology

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Expert Rankings

Top experts on the MeSH terms this expert works on

Organizations

Career arc: 2022 - 2026

Source: PubMed

St. Jude Children's Research Hospital

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 11

Citations

Citations: 27 1st author: 6 Last author: 0 Unique author: 0


Best Journals

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Clinical Functional Assignment of TPMT and NUDT15 Alleles by the Clinical Pharmacogenetics Implementation Consortium Pharmacogene Curation Expert Panel.
PMID 42560154 — pharmacogenetics, phenotype, drug therapy, pharmacology, work, alleles, therapeutics
Clin Pharmacol Ther20260
Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for Thiopurine Dosing Based on TPMT and NUDT15 Genotypes: 2025 Update.
PMID 41618934 — genes, pharmacogenetics, drug therapy, enzymes, pharmacology, genotype
Clin Pharmacol Ther20261
Model-Informed Precision Dosing of Protein Kinase Inhibitors: Evaluation of Model-Averaging and Flattened Priors Methods.
PMID 41801644 — sunitinib, protein kinases, protein kinase inhibitors, pharmacology, work
Clin Pharmacokinet20260
The genomic landscape of relapsed infant and childhood KMT2A-rearranged acute leukemia.
PMID 41062506 — biological science disciplines, pharmaceutical preparations, leukemia, therapeutics, infant
Nat Commun20250
Azathioprine Metabolites in Erythrocytes and DNA for Therapy Monitoring in Very Early Onset Inflammatory Bowel Disease Pediatric Patients.
PMID 40672687 — pharmacogenetics, erythrocytes, azathioprine, inflammatory bowel diseases, therapeutics, dna
ACS Pharmacol Transl Sci20251

LeadR Networks

Main global connection map